Global Guaifenesin (API) Market Growth 2019-2024

  • receipt Report ID : 180377
  • calendar_today Published On: Jul, 2019
  • file_copy Pages: 162
  • list Pharmaceuticals and Healthcare

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.

Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.

According to this study, over the next five years the Guaifenesin (API) market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 58 million by 2024, from US$ 56 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Guaifenesin (API) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Guaifenesin (API) market by product type, application, key manufacturers and key regions and countries.

This study considers the Guaifenesin (API) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

98%-99%

>99%

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Pharmaceuticals

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Granules

Synthokem Labs

Haizhou Pharma

Yuan Cheng Group

Stellar Chemical

Biesterfeld

Seven Star Pharma

Camlin Fine Science

Gennex Lab

Iwaki Seiyaku

Pan Drugs

Delta Synthetic

Smart Pharm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Guaifenesin (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Guaifenesin (API) market by identifying its various subsegments.

Focuses on the key global Guaifenesin (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Guaifenesin (API) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Guaifenesin (API) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

2019-2024 Global Guaifenesin (API) Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Guaifenesin (API) Consumption 2014-2024

2.1.2 Guaifenesin (API) Consumption CAGR by Region

2.2 Guaifenesin (API) Segment by Type

2.2.1 98%-99%

2.2.2 >99%

2.3 Guaifenesin (API) Consumption by Type

2.3.1 Global Guaifenesin (API) Consumption Market Share by Type (2014-2019)

2.3.2 Global Guaifenesin (API) Revenue and Market Share by Type (2014-2019)

2.3.3 Global Guaifenesin (API) Sale Price by Type (2014-2019)

2.4 Guaifenesin (API) Segment by Application

2.4.1 Pharmaceuticals

2.4.2 Others

2.5 Guaifenesin (API) Consumption by Application

2.5.1 Global Guaifenesin (API) Consumption Market Share by Application (2014-2019)

2.5.2 Global Guaifenesin (API) Value and Market Share by Application (2014-2019)

2.5.3 Global Guaifenesin (API) Sale Price by Application (2014-2019)

3 Global Guaifenesin (API) by Players

3.1 Global Guaifenesin (API) Sales Market Share by Players

3.1.1 Global Guaifenesin (API) Sales by Players (2017-2019)

3.1.2 Global Guaifenesin (API) Sales Market Share by Players (2017-2019)

3.2 Global Guaifenesin (API) Revenue Market Share by Players

3.2.1 Global Guaifenesin (API) Revenue by Players (2017-2019)

3.2.2 Global Guaifenesin (API) Revenue Market Share by Players (2017-2019)

3.3 Global Guaifenesin (API) Sale Price by Players

3.4 Global Guaifenesin (API) Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Guaifenesin (API) Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Guaifenesin (API) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Guaifenesin (API) by Regions

4.1 Guaifenesin (API) by Regions

4.1.1 Global Guaifenesin (API) Consumption by Regions

4.1.2 Global Guaifenesin (API) Value by Regions

4.2 Americas Guaifenesin (API) Consumption Growth

4.3 APAC Guaifenesin (API) Consumption Growth

4.4 Europe Guaifenesin (API) Consumption Growth

4.5 Middle East & Africa Guaifenesin (API) Consumption Growth

5 Americas

5.1 Americas Guaifenesin (API) Consumption by Countries

5.1.1 Americas Guaifenesin (API) Consumption by Countries (2014-2019)

5.1.2 Americas Guaifenesin (API) Value by Countries (2014-2019)

5.2 Americas Guaifenesin (API) Consumption by Type

5.3 Americas Guaifenesin (API) Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Guaifenesin (API) Consumption by Countries

6.1.1 APAC Guaifenesin (API) Consumption by Countries (2014-2019)

6.1.2 APAC Guaifenesin (API) Value by Countries (2014-2019)

6.2 APAC Guaifenesin (API) Consumption by Type

6.3 APAC Guaifenesin (API) Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Guaifenesin (API) by Countries

7.1.1 Europe Guaifenesin (API) Consumption by Countries (2014-2019)

7.1.2 Europe Guaifenesin (API) Value by Countries (2014-2019)

7.2 Europe Guaifenesin (API) Consumption by Type

7.3 Europe Guaifenesin (API) Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Guaifenesin (API) by Countries

8.1.1 Middle East & Africa Guaifenesin (API) Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Guaifenesin (API) Value by Countries (2014-2019)

8.2 Middle East & Africa Guaifenesin (API) Consumption by Type

8.3 Middle East & Africa Guaifenesin (API) Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Guaifenesin (API) Distributors

10.3 Guaifenesin (API) Customer

11 Global Guaifenesin (API) Market Forecast

11.1 Global Guaifenesin (API) Consumption Forecast (2019-2024)

11.2 Global Guaifenesin (API) Forecast by Regions

11.2.1 Global Guaifenesin (API) Forecast by Regions (2019-2024)

11.2.2 Global Guaifenesin (API) Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Guaifenesin (API) Forecast by Type

11.8 Global Guaifenesin (API) Forecast by Application

12 Key Players Analysis

12.1 Granules

12.1.1 Company Details

12.1.2 Guaifenesin (API) Product Offered

12.1.3 Granules Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Granules News

12.2 Synthokem Labs

12.2.1 Company Details

12.2.2 Guaifenesin (API) Product Offered

12.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Synthokem Labs News

12.3 Haizhou Pharma

12.3.1 Company Details

12.3.2 Guaifenesin (API) Product Offered

12.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Haizhou Pharma News

12.4 Yuan Cheng Group

12.4.1 Company Details

12.4.2 Guaifenesin (API) Product Offered

12.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Yuan Cheng Group News

12.5 Stellar Chemical

12.5.1 Company Details

12.5.2 Guaifenesin (API) Product Offered

12.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Stellar Chemical News

12.6 Biesterfeld

12.6.1 Company Details

12.6.2 Guaifenesin (API) Product Offered

12.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Biesterfeld News

12.7 Seven Star Pharma

12.7.1 Company Details

12.7.2 Guaifenesin (API) Product Offered

12.7.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Seven Star Pharma News

12.8 Camlin Fine Science

12.8.1 Company Details

12.8.2 Guaifenesin (API) Product Offered

12.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Camlin Fine Science News

12.9 Gennex Lab

12.9.1 Company Details

12.9.2 Guaifenesin (API) Product Offered

12.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Gennex Lab News

12.10 Iwaki Seiyaku

12.10.1 Company Details

12.10.2 Guaifenesin (API) Product Offered

12.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Iwaki Seiyaku News

12.11 Pan Drugs

12.12 Delta Synthetic

12.13 Smart Pharm

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Guaifenesin (API)

Table Product Specifications of Guaifenesin (API)

Figure Guaifenesin (API) Report Years Considered

Figure M

Please fill the form below, to recieve the report sample


+1